An interventional study of Standard Rehabilitation and Biofeedback Ultrasonography in Low Back Pain and Chronic Low Back Pain, sponsored by University of Rzeszow. Recruiting at 1 site in Poland. Open to participants aged 30 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-04-07.
Sponsored by University of Rzeszow · Not applicable, Interventional, and Treatment
The aim of the study is to evaluate the effects of biofeedback-assisted stabilization training and conventional therapy on pain perception, balance, spinal mobility, functional performance, physical activity, stress level, and quality of life in patients with lumbosacral spine pain syndrome treated conservatively. The main research questions the study seeks to answer are as follows: Whether and to what extent the implemented therapeutic program improves balance, spinal mobility, functional performance, physical activity, quality of life, and reduces pain perception and stress levels in patients with lumbosacral spine pain syndrome? Are there differences in therapeutic outcomes depending on the treatment method applied? Are the therapeutic effects maintained three months after completion of the intervention? Researchers will compare two groups: a control group and an experimental group. In the control group, stabilization training will be performed without the use of biofeedback. Participants will undergo clinical and functional assessments (Visual Analogue Scale, Oswestry Disability Index, force platform measurements, etc.). Depending on the group to which participants are randomly assigned, participants will participate in manual therapy, stabilization training, and selected physical therapy modalities. Participants will be continuously supervised by a physician and physiotherapists throughout the 8-week intervention period. Three months after completion of the intervention, participants will undergo a follow-up assessment.
The study is interventional, prospective, randomized, and controlled in design. Its objective is to determine whether stabilization training using ultrasonography as a biofeedback tool leads to improved therapeutic outcomes compared with standard physiotherapy. The intervention is intended for patients with chronic lumbosacral spine pain lasting at least three months. Eligibility for participation will be based on clearly defined inclusion criteria. This study will be conducted at REHA MEDICA Rehabilitation and Medical Center in Tarnów, Poland. The investigators plan to enroll approximately 110 patients, with 55 assigned to the control group and 55 to the experimental group.
The therapeutic program in both groups will include manual therapy, selected physical therapy modalities, and therapeutic exercises. Participants will be randomly assigned to either a control group or an experimental group. In the experimental group, biofeedback in the form of ultrasonography will be used during stabilization exercises, whereas in the control group, exercises will be performed without biofeedback.
The following parameters will be analyzed: pain intensity, the degree of disability associated with spinal pain, spinal range of motion, balance parameters assessed using a force platform, level of physical activity, stress severity, and self-reported quality of life.
The following tests and questionnaires will be used in the study:
The force platform will be used to assess balance, including center of pressure (COP) position, COP path length, COP displacement speed, sway range in the sagittal and frontal planes, percentage load on the right and left lower limbs during double-leg stance, and postural control with eyes open and eyes closed.
Inclinometer - for measuring the lumbar lordosis angle and the range of motion of the lumbosacral spine.
STarT Back Screening Tool - a questionnaire assessing the risk of developing chronic low back pain.
Oswestry Disability Index (ODI) - an index measuring disability related to lumbosacral spine pain.
McGill Pain Questionnaire - Short Form - evaluating pain quality and intensity. Visual Analog Scale (VAS) - for assessing pain intensity. Physical Activity Questionnaire - assessing the level of physical activity over the past seven days.
Perceived Stress Scale - a subjective measure of stress experienced over the past month.
WHOQOL-BREF - a quality of life questionnaire developed by the World Health Organization (World Health Organization Quality of Life - BREF).
Before entering the program, participants will be examined by a specialist in rehabilitation medicine. Subsequently, the principal investigator (physiotherapist) will conduct a baseline assessment including all analyzed parameters. After completing the qualification process, participants will begin an 8-week physiotherapy program conducted twice weekly. Immediately after completion of the intervention, a post-treatment assessment identical to the baseline evaluation will be performed. A follow-up assessment will then be conducted three months after completion of the therapy.
The study will be conducted under the supervision of qualified medical personnel and in accordance with all applicable safety standards. The results will determine whether the use of ultrasonography-based biofeedback improves clinical and functional outcomes and whether any therapeutic benefits are maintained over time. The findings may contribute to the optimization of rehabilitation programs for patients with chronic lumbosacral spine pain.
2,922 studies on the registry are indexed under Low Back Pain; 580 are open to participants now.
This study's planned enrollment of 110 is above the median of 60 across 2,364 interventional studies indexed under Low Back Pain.
Browse Low Back Pain studies →University of Rzeszow is the lead sponsor of 37 studies on the registry; 12 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Autoimmune disease
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The investigators use in this group standard physiotherapy and ultrasonography as Biofeedback-Assisted Stabilization Training to activate deep muscle of spine.
Other: Standard Rehabilitation · Other: Biofeedback Ultrasonography
In this group the investigators use standard physiotherapy without ultrasonography as biofeedback.
Other: Standard Rehabilitation
Standard Rehabilitation; Participants in the experimental group will undergo an 8-week rehabilitation program (2 sessions per week) that includes: Manual therapy, Physical therapy modalities, including TENS (Transcutaneous Electrical Nerve Stimulation) and therapeutic ultrasound, applied according to current conservative treatment standards, Standard exercises including muscle stretching, neural mobilization, diaphragmatic breathing, and exercises targeting deep trunk muscles.
Biofeedback Ultrasonography: exercises targeting the deep muscles of the spine, performed using ultrasonography for motor learning. The biofeedback allows real-time visualization of deep muscle activation (e.g., transverse abdominal, Pelvic floor muscles), helping participants optimize contraction patterns and improve neuromuscular control of the lumbosacral spine.
Balance
Measurement Tool: Force platform Unit of Measure: Numerical and percentage values determined by the electronic device; includes center of pressure (COP) position, COP path length, COP displacement speed, sway range in sagittal and frontal planes, percentage load on right and left lower limbs during double-leg stance, and postural control with eyes open and eyes closed
Time frame: First examination - before the start of the rehabilitation program
Balance
Measurement Tool: Force platform Unit of Measure: Numerical and percentage values determined by the electronic device; includes center of pressure (COP) position, COP path length, COP displacement speed, sway range in sagittal and frontal planes, percentage load on right and left lower limbs during double-leg stance, and postural control with eyes open and eyes closed
Time frame: Second examination - at the end of the eight-week program
Balance
Measurement Tool: Force platform Unit of Measure: Numerical and percentage values determined by the electronic device; includes center of pressure (COP) position, COP path length, COP displacement speed, sway range in sagittal and frontal planes, percentage load on right and left lower limbs during double-leg stance, and postural control with eyes open and eyes closed
Time frame: Follow-up assessment at 3 months post-intervention.
Pain intensity Visual Analog Scale
The Visual Analog Scale (VAS) Unit of Measure: Pain intensity is measured on a scale from 0 to 10 using the Visual Analog Scale (VAS), where 0 represents no pain and 10 represents the worst pain imaginable. Higher scores indicate greater pain intensity Measurement Tool: The Visual Analog Scale (VAS) will be used to allow patients to self-report perceived pain intensity.
Time frame: First examination - before the start of the rehabilitation program
Pain intensity Visual Analog Scale
The Visual Analog Scale (VAS) Unit of Measure: Pain intensity is measured on a scale from 0 to 10 using the Visual Analog Scale (VAS), where 0 represents no pain and 10 represents the worst pain imaginable. Higher scores indicate greater pain intensity Measurement Tool: The Visual Analog Scale (VAS) will be used to allow patients to self-report perceived pain intensity.
Time frame: Second examination - at the end of the eight-week program
Pain intensity Visual Analog Scale
The Visual Analog Scale (VAS) Unit of Measure: Pain intensity is measured on a scale from 0 to 10 using the Visual Analog Scale (VAS), where 0 represents no pain and 10 represents the worst pain imaginable. Higher scores indicate greater pain intensity Measurement Tool: The Visual Analog Scale (VAS) will be used to allow patients to self-report perceived pain intensity.
Time frame: Follow-up assessment at 3 months post-intervention.
Pain Questionnaire
McGill Pain Questionnaire - Short Form; Evaluation: The McGill Pain Questionnaire - Short Form is a concise tool (15 descriptors) for rapid, multidimensional assessment of pain, including sensory and affective components, as well as pain intensity. Unit of Measure: Patients rate each descriptor on a scale from 0 to 3 (0 = none, 3 = severe). Higher total scores indicate more intense and distressing pain. Measurement Tool: The Short-Form McGill Pain Questionnaire (SF-MPQ) will be used to allow patients to self-report both the intensity and qualitative characteristics of participants pain.
Time frame: First examination - before the start of the rehabilitation program
Pain Questionnaire
McGill Pain Questionnaire - Short Form; Evaluation: The McGill Pain Questionnaire - Short Form is a concise tool (15 descriptors) for rapid, multidimensional assessment of pain, including sensory and affective components, as well as pain intensity. Unit of Measure: Patients rate each descriptor on a scale from 0 to 3 (0 = none, 3 = severe). Higher total scores indicate more intense and distressing pain. Measurement Tool: The Short-Form McGill Pain Questionnaire (SF-MPQ) will be used to allow patients to self-report both the intensity and qualitative characteristics of participants pain.
Time frame: Second examination - at the end of the eight-week program
Pain Questionnaire
McGill Pain Questionnaire - Short Form; Evaluation: The McGill Pain Questionnaire - Short Form is a concise tool (15 descriptors) for rapid, multidimensional assessment of pain, including sensory and affective components, as well as pain intensity. Unit of Measure: Patients rate each descriptor on a scale from 0 to 3 (0 = none, 3 = severe). Higher total scores indicate more intense and distressing pain. Measurement Tool: The Short-Form McGill Pain Questionnaire (SF-MPQ) will be used to allow patients to self-report both the intensity and qualitative characteristics of participants pain.
Time frame: Follow-up assessment at 3 months post-intervention.
Disability related to spinal pain
Assessment of disability related to spinal pain using the Oswestry Disability Index (ODI). Evaluation: Functional disability associated with lumbosacral spine pain. Unit of Measure: The ODI score is expressed as a percentage, calculated from 10 sections (0-5 points each). The total score ranges from 0% to 100%, where higher scores indicate greater disability. Interpretation of scores is as follows: 0-20%: Minimal disability 21-40%: Moderate disability 41-60%: Severe disability 61-80%: Crippling disability 81-100%: Bed-bound or exaggerating symptoms Measurement Tool: The Oswestry Disability Index (ODI) questionnaire will be used to allow patients to self-report limitations in daily activities related to spinal pain.
Time frame: First examination - before the start of the rehabilitation program
Disability related to spinal pain
Assessment of disability related to spinal pain using the Oswestry Disability Index (ODI). Evaluation: Functional disability associated with lumbosacral spine pain. Unit of Measure: The ODI score is expressed as a percentage, calculated from 10 sections (0-5 points each). The total score ranges from 0% to 100%, where higher scores indicate greater disability. Interpretation of scores is as follows: 0-20%: Minimal disability 21-40%: Moderate disability 41-60%: Severe disability 61-80%: Crippling disability 81-100%: Bed-bound or exaggerating symptoms Measurement Tool: The Oswestry Disability Index (ODI) questionnaire will be used to allow patients to self-report limitations in daily activities related to spinal pain.
Time frame: Second examination - at the end of the eight-week program
Disability related to spinal pain
Assessment of disability related to spinal pain using the Oswestry Disability Index (ODI). Evaluation: Functional disability associated with lumbosacral spine pain. Unit of Measure: The ODI score is expressed as a percentage, calculated from 10 sections (0-5 points each). The total score ranges from 0% to 100%, where higher scores indicate greater disability. Interpretation of scores is as follows: 0-20%: Minimal disability 21-40%: Moderate disability 41-60%: Severe disability 61-80%: Crippling disability 81-100%: Bed-bound or exaggerating symptoms Measurement Tool: The Oswestry Disability Index (ODI) questionnaire will be used to allow patients to self-report limitations in daily activities related to spinal pain.
Time frame: Follow-up assessment at 3 months post-intervention.
Spinal Range of Motion
Spinal range of motion Evaluation: Mobility of the lumbar and lumbosacral spine. Unit of Measure: Degrees (°) of motion measured with an inclinometer; includes lumbar flexion, extension, lateral bending, and rotation. Higher values indicate greater spinal mobility. Measurement Tool: Inclinometer will be used to quantify exact angles of spinal movements.
Time frame: First examination - before the start of the rehabilitation program
Spinal Range of Motion
Spinal range of motion Evaluation: Mobility of the lumbar and lumbosacral spine. Unit of Measure: Degrees (°) of motion measured with an inclinometer; includes lumbar flexion, extension, lateral bending, and rotation. Higher values indicate greater spinal mobility. Measurement Tool: Inclinometer will be used to quantify exact angles of spinal movements.
Time frame: Second examination - at the end of the eight-week program
Spinal Range of Motion
Spinal range of motion Evaluation: Mobility of the lumbar and lumbosacral spine. Unit of Measure: Degrees (°) of motion measured with an inclinometer; includes lumbar flexion, extension, lateral bending, and rotation. Higher values indicate greater spinal mobility. Measurement Tool: Inclinometer will be used to quantify exact angles of spinal movements.
Time frame: Follow-up assessment at 3 months post-intervention.
Physical activity level
Evaluation: Level of physical activity over the past seven days. Unit of Measure: Physical activity is expressed in MET-minutes/week based on the IPAQ - International Physical Activity Questionnaire (Short Form, SF). The questionnaire contains 7 questions regarding time spent on vigorous activity, moderate activity, walking, and sitting over the past 7 days. Interpretation of MET scores: \<600 MET-min/week: Low physical activity 600-3000 MET-min/week: Moderate physical activity 3000 MET-min/week: High physical activity Measurement Tool: IPAQ - International Physical Activity Questionnaire (Short Form, SF) self-reported by participants to assess frequency, duration, and intensity of physical activity.
Time frame: First examination - before the start of the rehabilitation program
Physical activity level
Evaluation: Level of physical activity over the past seven days. Unit of Measure: Physical activity is expressed in MET-minutes/week based on the IPAQ - International Physical Activity Questionnaire (Short Form, SF). The questionnaire contains 7 questions regarding time spent on vigorous activity, moderate activity, walking, and sitting over the past 7 days. Interpretation of MET scores: \<600 MET-min/week: Low physical activity 600-3000 MET-min/week: Moderate physical activity 3000 MET-min/week: High physical activity Measurement Tool: IPAQ - International Physical Activity Questionnaire (Short Form, SF) self-reported by participants to assess frequency, duration, and intensity of physical activity.
Time frame: Second examination - at the end of the eight-week program
Physical activity level
Evaluation: Level of physical activity over the past seven days. Unit of Measure: Physical activity is expressed in MET-minutes/week based on the IPAQ - International Physical Activity Questionnaire (Short Form, SF). The questionnaire contains 7 questions regarding time spent on vigorous activity, moderate activity, walking, and sitting over the past 7 days. Interpretation of MET scores: \<600 MET-min/week: Low physical activity 600-3000 MET-min/week: Moderate physical activity 3000 MET-min/week: High physical activity Measurement Tool: IPAQ - International Physical Activity Questionnaire (Short Form, SF) self-reported by participants to assess frequency, duration, and intensity of physical activity.
Time frame: Follow-up assessment at 3 months post-intervention.
Stress level
Evaluation: Perceived stress experienced over the past month. Unit of Measure: Numerical score from the Perceived Stress Scale (PSS-10). The questionnaire contains 10 questions, each scored from 0 to 4 points, giving a maximum total score of 40 points. Higher scores indicate higher levels of perceived stress. Measurement Tool: Perceived Stress Scale (PSS-10) self-reported by participants to assess subjective stress over the past month.
Time frame: First examination - before the start of the rehabilitation program
Stress level
Evaluation: Perceived stress experienced over the past month. Unit of Measure: Numerical score from the Perceived Stress Scale (PSS-10). The questionnaire contains 10 questions, each scored from 0 to 4 points, giving a maximum total score of 40 points. Higher scores indicate higher levels of perceived stress. Measurement Tool: Perceived Stress Scale (PSS-10) self-reported by participants to assess subjective stress over the past month.
Time frame: Second examination - at the end of the eight-week program
Stress level
Evaluation: Perceived stress experienced over the past month. Unit of Measure: Numerical score from the Perceived Stress Scale (PSS-10). The questionnaire contains 10 questions, each scored from 0 to 4 points, giving a maximum total score of 40 points. Higher scores indicate higher levels of perceived stress. Measurement Tool: Perceived Stress Scale (PSS-10) self-reported by participants to assess subjective stress over the past month.
Time frame: Follow-up assessment at 3 months post-intervention.
Quality of life questionnaire
Evaluation: Concise questionnaire used for subjective assessment of quality of life in both healthy and patient populations. It evaluates four main domains: physical, psychological, social relationships, and environment. Unit of Measure: Standardized numerical scores (0-100 points) for each domain, where higher scores indicate better quality of life. Measurement Tool: WHOQOL-BREF self-reported by participants to assess perceived quality of life across the four domains.
Time frame: First examination - before the start of the rehabilitation program
Quality of life questionnaire
Evaluation: Concise questionnaire used for subjective assessment of quality of life in both healthy and patient populations. It evaluates four main domains: physical, psychological, social relationships, and environment. Unit of Measure: Standardized numerical scores (0-100 points) for each domain, where higher scores indicate better quality of life. Measurement Tool: WHOQOL-BREF self-reported by participants to assess perceived quality of life across the four domains.
Time frame: Second examination - at the end of the eight-week program
Quality of life questionnaire
Evaluation: Concise questionnaire used for subjective assessment of quality of life in both healthy and patient populations. It evaluates four main domains: physical, psychological, social relationships, and environment. Unit of Measure: Standardized numerical scores (0-100 points) for each domain, where higher scores indicate better quality of life. Measurement Tool: WHOQOL-BREF self-reported by participants to assess perceived quality of life across the four domains.
Time frame: Follow-up assessment at 3 months post-intervention.
Risk of developing chronic low back pain
Evaluation: Likelihood of persistent low back pain becoming chronic. Unit of Measure: Categorical score using the STarT Back Screening Tool. The questionnaire consists of 9 questions referring to the past two weeks, with each question answered as agree or disagree. Participants are classified as low, medium, or high risk based on total responses. Measurement Tool: STarT Back Screening Tool self-reported by participants to assess risk of developing chronic low back pain.
Time frame: First examination - before the start of the rehabilitation program
Risk of developing chronic low back pain
Evaluation: Likelihood of persistent low back pain becoming chronic. Unit of Measure: Categorical score using the STarT Back Screening Tool. The questionnaire consists of 9 questions referring to the past two weeks, with each question answered as agree or disagree. Participants are classified as low, medium, or high risk based on total responses. Measurement Tool: STarT Back Screening Tool self-reported by participants to assess risk of developing chronic low back pain.
Time frame: Second examination - at the end of the eight-week program
Risk of developing chronic low back pain
Evaluation: Likelihood of persistent low back pain becoming chronic. Unit of Measure: Categorical score using the STarT Back Screening Tool. The questionnaire consists of 9 questions referring to the past two weeks, with each question answered as agree or disagree. Participants are classified as low, medium, or high risk based on total responses. Measurement Tool: STarT Back Screening Tool self-reported by participants to assess risk of developing chronic low back pain.
Time frame: Follow-up assessment at 3 months post-intervention.
Plan to share: No
No publications or documents are linked to this record.
Started Apr 2026 (actual). Primary completion is estimated for May 2027, 13 months after the start.
Of 1,231 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's planned 13 months is above that.
Counting every sponsor, half of 1,286 studies reached it within 11 months; a quarter within 5 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Rzeszow